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Abstract
Aims/hypothesis The common genetic and environmental
effects on endophenotypes related to the metabolic syn-
drome have been investigated using bivariate and multivar-
iate twin models. This paper extends the pairwise analysis
approach by introducing independent and common pathway
models to Chinese twin data. The aim was to explore the
common genetic architecture in the development of these
phenotypes in the Chinese population.
Methods Three multivariate models including the full
saturated Cholesky decomposition model, the common
factor independent pathway model and the common factor
common pathway model were fitted to 695 pairs of Chinese
twins representing six phenotypes including BMI, total
cholesterol, total triacylglycerol, fasting glucose, HDL and
LDL. Performances of the nested models were compared
with that of the full Cholesky model.
Results Cross-phenotype correlation coefficients gave clear
indication of common genetic or environmental back-
grounds in the phenotypes. Decomposition of phenotypic
correlation by the Cholesky model revealed that the
observed phenotypic correlation among lipid phenotypes
had genetic and unique environmental backgrounds. Both
pathway models suggest a common genetic architecture for
lipid phenotypes, which is distinct from that of the non-
lipid phenotypes. The declining performance with model
restriction indicates biological heterogeneity in develop-
ment among some of these phenotypes.
Conclusions/interpretation Our multivariate analyses
revealed common genetic and environmental backgrounds
for the studied lipid phenotypes in Chinese twins. Model
performance showed that physiologically distinct endophe-
notypes may follow different genetic regulations.
Keywords Chinese twins . Endophenotypes .Metabolic
phenotype .Multivariate analysis . Pathway models
Abbreviations
ACE Additive genetic, common environment, and
unique environment (source of variance)
AIC Akaike’s Information Criterion
CP Common pathway model
GWA Genome-wide association
IP Independent pathway model
Z. Pang and D. Zhang contributed equally to this work.
Z. Pang (*) :H. Duan
Qingdao Center for Disease Control and Prevention,
No 175, Shandong Road, Sifang District,
266033 Qingdao, China
e-mail: cdcpang@126.com
Z. Pang :D. Zhang (*)
Department of Public Health,
Qingdao University Medical College,
Deng Zhou Street 38,
266021 Qingdao, China
e-mail: zhangdf1961@126.com
S. Li :K. O. Kyvik :K. Christensen :Q. Tan
Epidemiology, Institute of Public Health,
University of Southern Denmark,
Odense, Denmark
J. Hjelmborg
Department of Biostatistics, Institute of Public Health,
University of Southern Denmark,
Odense, Denmark
T. A. Kruse :Q. Tan
Department of Clinical Genetics, Odense University Hospital,
Odense, Denmark
K. O. Kyvik
Institute for Regional Health Services Research,
University of Southern Denmark,
Odense, Denmark
Diabetologia (2010) 53:2554–2561
DOI 10.1007/s00125-010-1907-5
Introduction
The metabolic syndrome is a complex and composite disorder
in which multiple phenotypes pertaining to morphological (e.
g. BMI) and biochemical (e.g. fasting glucose, total choles-
terol, triacylglycerol, etc.) alterations of an affected individual
are implicated. Genetic epidemiological studies using related
individuals, including twins, have shown that genetic and
environmental factors make important contributions to the
development of the disorder and its associated phenotypes.
Instead of phenotype-wise univariate analysis, there has been
an increasing interest in study of the so-called pleiotropic
effects that affect multiple traits associated with the metabolic
syndrome. Such approaches have used bivariate [1–3] and
multivariate [4] modelling, with results indicating common
genetic and environmental mechanisms among sub-clusters
of phenotypes related to the metabolic syndrome.
Common and independent pathway models represent an
important multivariate modelling approach in twin data
analysis. The pathway models have been applied in twin
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Fig. 2 The common factor IP
model assumes common genetic
and environmental factors but
with different effects on the six
phenotypes, while restricting
and decomposing the cross-
phenotype correlation into com-
mon genetic and environmental
(including shared and unique)
components. GLU, fasting glu-
cose; TC, total cholesterol; TG,
triacylglycerol. Ac, Cc, and Ec
are the additive genetic, shared
and unshared environmental
components for the common
factors; As, Cs, and Es are the
additive genetic, shared and un-
shared environmental compo-
nents for the phenotype-specific
effects
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Fig. 1 The common factor CP
model restricts the common ge-
netic and environmental factors
leading to the same genetic and
environmental architecture for
all phenotypes by introducing a
single latent phenotype. GLU,
fasting glucose; TC, total cho-
lesterol; TG, triacylglycerol. Ac,
Cc, and Ec are the additive
genetic, shared and unshared
environmental components for
the common factors; As, Cs, and
Es are the additive genetic,
shared and unshared environ-
mental components for the
phenotype-specific effects
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studies of complex human traits, including, for example,
behaviour [5, 6] and cardiovascular disorders [7], and have
revealed common genetic and environmental factors under-
lying the sub-phenotypes associated with these composite
phenotypes. Likewise, pathway modelling of endophenotypes
associated with the metabolic syndrome could help identify
the pleiotropy in the development of the disorder’s sub-
phenotypes, eventually leading to more efficient treatment and
prevention strategies. This paper reports results from our
pathway modelling of multiple sub-phenotypes of the meta-
bolic syndrome collected by the Qingdao Twin Registry
(Qingdao Center for Disease Control and Prevention, Qingdao)
in China, where prevalence of metabolic disorders is increasing
rapidly due to changing life style and dietary structures, both
of which have been undergoing steady westernisation.
Methods
Participants Starting from 2001 when the Qingdao Twin
Registry, the largest twin registry in China, was first
established at Qingdao Center for Disease Control and
Prevention, anthropometric and experimental data on
metabolic phenotypes have been collected in monozygotic
and dizygotic twins in different phases conducted in 2001,
2004 and 2008. At each phase, twins were sampled through
the local disease control network and residence registry.
Those who were pregnant, breastfeeding, had known
diabetes and/or cardiovascular disease, or had taken
weight-reducing medication within 1 month of sampling
were excluded; incomplete twin pairs were discharged. A
total of 695 pairs of twins (405 monozygotic, 290 dizygotic
pairs) with a mean age of 37 years was available for analysis.
Zygosity of same-sex twin pairs was determined by DNA
testing using 16 short tandem repeat DNA markers.
Phenotype BMI HDL LDL GLU TC TG
Additive genetic
BMI 1.00
HDL 0.06 1.00
LDL 0.07 0.68 1.00
GLU 0.22 −0.22 −0.18 1.00
TC 0.08 0.73 0.93 −0.07 1.00
TG 0.34 0.07 0.24 0.23 0.30 1.00
Common environment
BMI 1.00
HDL −0.30 1.00
LDL 0.62 0.49 1.00
GLU 0.11 −0.02 −0.14 1.00
TC 0.60 0.00 0.75 −0.16 1.00
TG 0.76 −0.20 0.70 −0.15 0.97 1.00
Unique environment
BMI 1.00
HDL 0.10 1.00
LDL 0.22 0.63 1.00
GLU 0.11 0.20 0.20 1.00
TC 0.20 0.78 0.88 0.23 1.00
TG 0.31 0.14 0.42 0.07 0.37 1.00
Table 2 Estimated genetic and
environmental correlation coef-
ficients for the full Cholesky
decomposition model
GLU Fasting glucose, TC Total
cholesterol, TG Triacylglycerol
Table 1 Inter-phenotype correlation, mean and standard deviation for
all log-transformed phenotypes
Phenotype BMI HDL LDL GLU TC TG
BMI 1.00
HDL 0.07 1.00
LDL 0.23 0.62 1.00
GLU 0.19 0.02* 0.02* 1.00
TC 0.21 0.58 0.84 0.06 1.00
TG 0.39 0.07 0.41 0.09 0.45 1.00
Mean 3.17a 0.37b 1.06b 1.56b 1.61b 0.02b
SD 0.13 0.24 0.27 0.13 0.22 0.51
Correlations were corrected for age and sex.
aMeasured as kg/m2 ; b measured as mmol/l
*p>0.05
GLU Fasting glucose, TC Total cholesterol, TG Triacylglycerol
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All participants gave informed consent and the study
was approved by the local Ethics Committee at Qingdao
Center for Disease Control and Prevention.
Phenotypes Under consideration of representativeness for
pathway modelling in a sample of limited size, we selected
six phenotypes associated with the metabolic syndrome.
These included: BMI, LDL, HDL, fasting glucose, total
cholesterol and triacylglycerol. All these phenotypes were
measured using standard procedures. For individuals who
had repeated measurements over the three phases, only the
earliest measurements were kept to avoid correlated data
structure due to multiple measurements from the same
individual. All phenotype values were log-transformed
(natural log) to avoid skewed phenotype distributions.
Any measurement that was more than 3 SD below or
above the mean was assigned as a missing value.
Data analysis We introduced and fitted three multivari-
ate models, the Cholesky decomposition [8] (also known
as the full saturated model), the common factor indepen-
dent pathway (IP) model (also called the biometric
model) and the common factor common pathway (CP)
model (the psychometric model) [9]. The Cholesky
decomposition includes as many factors as phenotypes
(six in this study) for each independent source of variance
(additive genetic, A; common environment, C; and
unique environment, E), with the first factor loading on
all phenotypes, the second on all but the first, the third on
all but the first two and so on. The saturated least
restrictive Cholesky decomposition provides the fullest
potential explanation of the data and thus can serve as the
base model for comparison with the nested IP and CP
models.
The CP model is a restrictive model under the hypothesis
that the covariance between phenotypes is due to a single
shared latent phenotype determined in turn by latent genetic
and environmental factors (Fig. 1). On the other hand, the
IP model assumes a more flexible factor model under the
hypothesis that the variance and covariance between
Table 3 Estimates and corresponding variance components for the IP model
Variance per phenotype Source of variance
Ac Cc Ec As Cs Es
BMI
Estimate 0.05 0.01 0.01 0.10 0.00 0.06
95% CI 0.04, 0.06 −0.01, 0.02 0.00, 0.02 0.09, 0.11 −0.05, 0.05 0.05, 0.06
Proportion of variance 0.15 0.01 0.01 0.61 0.00 0.22
HDL
Estimate 0.00 0.14 0.12 0.09 0.10 0.08
95% CI 0.00, 0.02 0.13, 0.15 0.11, 0.13 0.06, 0.12 0.06, 0.12 0.07, 0.09
Proportion of variance 0.00 0.34 0.25 0.14 0.16 0.11
LDL
Estimate 0.11 0.19 0.14 0.05 0.00 0.07
95% CI 0.09, 0.14 0.17, 0.21 0.13, 0.15 0.02, 0.07 −0.05, 0.05 0.06, 0.07
Proportion of variance 0.16 0.48 0.26 0.03 0.00 0.07
Fasting glucose
Estimate 0.02 0.01 0.02 0.07 0.08 0.08
95% CI 0.01, 0.03 0.00, 0.02 0.01, 0.02 0.05, 0.09 0.06, 0.10 0.07, 0.08
Proportion of variance 0.02 0.01 0.02 0.27 0.34 0.34
Total cholesterol
Estimate 0.09 0.13 0.13 0.03 0.08 0.00
95% CI 0.08, 0.12 0.11, 0.15 0.12, 0.14 −0.05, 0.05 0.07, 0.09 −0.01, 0.01
Proportion of variance 0.17 0.34 0.34 0.02 0.13 0.00
Triacylglycerol
Estimate 0.42 0.03 0.08 0.00 0.00 0.29
95% CI 0.38, 0.45 −0.04, 0.08 0.06, 0.11 −0.16, 0.16 −0.12, 0.12 0.27, 0.31
Proportion of variance 0.67 0.00 0.02 0.00 0.00 0.31
Ac, Cc, and Ec are the additive genetic, shared and unshared environmental components for the common factors with different factor loading;
As, Cs, and Es are the additive genetic, shared and unshared environmental components for the phenotype-specific effects
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phenotypes is caused by one or more common factors with
the residual variance accounted for by phenotype-specific
genetic and environmental effects (Fig. 2). Both IP and CP
models are nested sub-models of the fully saturated
Cholesky model, such that model comparison can be easily
done using a likelihood ratio test with the degree of
freedom set as the difference in the number of variables
specified. As a balance between model fit and parsimony in
the number of variables, the Akaike’s Information Criterion
(AIC) [10] was also used to determine the suitability of
models, with the best model being that with the lowest AIC.
In all model fitting, age and sex were included as covariates
to adjust for their effects on the six phenotypes. Robustness of
analysis was assessed using bootstrap re-sampling to calculate
empirical 95% CIs for estimated variables.
All twin modelling was performed using the Mx
package, which is freely available at www.psy.vu.nl/mxbib/
(accessed 17 March 2010).
Results
Table 1 shows the cross-phenotype correlation, the Pearson
correlation coefficient and basic statistics for each of the six
phenotypes adjusted for age and sex. Except for fasting
glucose with HDL and LDL, all other combinations displayed
significant cross-phenotype co-variation with: (1) high corre-
lation between total cholesterol and LDL (0.84); (2) moderate
to high correlation between LDL and HDL (0.62), and total
cholesterol and HDL (0.58); (3) moderate correlation between
triacylglycerol and total cholesterol (0.45), triacylglycerol and
LDL (0.41), and triacylglycerol and BMI (0.39); and (4) low
but significant correlation between BMI and all other
phenotypes, and between triacylglycerol and HDL and fasting
glucose. All these significant cross-phenotype correlations
give a clear indication of common genetic or environmental
backgrounds among the six endophenotypes to be decom-
posed by twin modelling.
Models −2LL AIC χ2 test df Δdf p value
Full ACE Cholesky 7,261.26 −23,625.26 8,182 – –
Independent pathway 6,841.49 −23,283.49 419.77 8,221 39 2.52×10−65
Common pathway 6,570.56 −23,032.56 690.70 8,231 49 3.94×10−114
Table 5 Comparison of model
performance for the three
multivariate models
2LL is two times the log
likelihood
Variance per phenotype Pathways
A C E Common
Latent phenotype
Estimate 0.74 0.42 0.52
95% CI 0.61, 0.86 −0.59, 0.59 0.48, 0.57
BMI
Estimate 0.11 0.00 0.06 0.03
95% CI 0.10, 0.12 −0.05, 0.05 0.05, 0.06
HDL
Estimate 0.11 0.12 0.08 0.17
95% CI 0.09, 0.13 0.09, 0.14 0.08, 0.09
LDL
Estimate 0.06 0.06 0.07 0.24
95% CI 0.03, 0.08 0.03, 0.09 0.06, 0.07
Fasting glucose
Estimate 0.07 0.09 0.08 0.02
95% CI 0.05, 0.09 0.07, 0.10 0.07, 0.08
Total cholesterol
Estimate 0.01 0.06 0.00 0.22
95% CI −0.05, 0.05 0.05, 0.08 −0.01, 0.01
Triacylglycerol
Estimate 0.36 0.00 0.28 0.23
95% CI 0.30, 0.39 −0.19, 0.19 0.26, 0.30
Table 4 Estimates and
corresponding variance compo-
nents for the CP model
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The genetic and environmental effects in phenotype
correlation were first modelled by the full Cholesky
decomposition with genetic and environmental correlation
coefficients estimated (Table 2). Here, correlations ob-
served were as follows: (1) very high genetic correlations
for total cholesterol and LDL (0.93); (2) moderate to high
genetic correlation for HDL with total cholesterol (0.73)
and HDL with LDL (0.68); (3) very high shared environmen-
tal correlation between total cholesterol and triacylglycerol
(0.97); (4) moderate to high shared environmental correlation
between LDL and total cholesterol (0.75), LDL and triacyl-
glycerol (0.70), BMI and LDL (0.62), BMI and total
cholesterol (0.60), and BMI and triacylglycerol (0.76); (5)
moderate to high unique environmental correlation between
total cholesterol and HDL (0.78), total cholesterol and LDL
(0.88), and between LDL and HDL (0.63).
In the IP model (Fig. 2), strong factor loadings for
common factor genetic effect, shared environmental effect
and unique environmental effects were found for total
cholesterol and LDL. Strong factor loadings were also
found with triacylglycerol for common factor genetic
effect and with HDL for non-genetic common factors.
The above suggests common genetic and environmental
mechanisms among these lipid phenotypes (Table 3).
Common factor genetic effect was also estimated for
BMI and accounts for 15% of the total variation in BMI.
Of special interest is the finding that high proportions of
variation in BMI and fasting glucose are due to their
unique pathways and include genetic, shared environmen-
tal and unique environmental components, with specific
genetic effect accounting for as high as 61% of variation
in BMI. The results mean that these two phenotypes are
more distinct from the lipid phenotypes. Even among the
lipid phenotypes, about 40% of variation in HDL can be
ascribed to its specific pathway.
In the more restricted CP model (Fig. 1), the latent
phenotype was mainly characterised by a common genetic
factor (Table 4) with 55% of variance accounted for by the
genetic factor (path coefficient 0.74), 18% by shared
environment (path coefficient 0.42) and 27% by unique
environment (path coefficient 0.52). Factor loadings on the
latent phenotype were mainly by the four lipid phenotypes,
i.e. LDL (0.24), triacylglycerol (0.23), total cholesterol (0.22)
and HDL (0.17). Similarly to the IP model, BMI and fasting
glucose were mainly characterised by their phenotype-specific
genetic and environmental mechanisms (Table 4).
In Table 5, performance of the three multivariate models
is compared using AIC and the likelihood ratio test, with
the full additive genetic, common environment, and unique
environment (source of variance) (ACE) Cholesky model as
the baseline model. The results in Table 5 show that the full
ACE Cholesky model performed significantly better than
the restricted IP and the CP models. Comparing the AICs, it
is clear that the more restricted the model, the worse the
performance.
Discussion
There have been many multivariate studies on phenotypes
related to the metabolic syndrome [3, 4] or obesity [2]
using bivariate or multivariate Cholesky decompositions.
The current study is characterised by two points. First,
comparative modelling of multiple phenotypes was done
by fitting the full saturated Choesky model and its nested
sub-models, with restrictions in common and independent
pathways, aiming to simultaneously evaluate the genetic
and environmental correlations among multiple pheno-
types. More than the pairwise analysis [1, 3], our
multivariate approach allows modelling of pathway models
with a view to examining the shared genetic and environ-
mental mechanisms among groups of phenotypes. Second,
our study included multiple phenotypes of biochemical
measurements instead of closely correlated morphological
measurements, and assumed that physiologically related
biochemical endophenotypes could share a common genetic
architecture.
As shown in Table 1, modest to high cross-phenotype
correlations were mainly seen in the lipid phenotypes, i.e.
among total cholesterol, HDL and LDL. Fasting glucose
was least correlated with all phenotypes except BMI. This
is interesting because such a pattern in phenotypic
correlation could indicate that: (1) glucose and lipid
metabolisms could be controlled by different biological
processes; and (2) BMI is representative of all endopheno-
types and thus a valuable measurement for studying
metabolic disorders.
By decomposing phenotypic correlation into additive
genetic, shared and unique environmental correlations, the
variable estimates by Cholesky decomposition (Table 2)
further revealed that the observed phenotype correlation
among lipid phenotypes had both genetic and unique
Models −2LL AIC χ2 test df Δdf p value
Full ACE Cholesky 2,830.72 −13,766.72 5,468 – –
Independent pathway 2,221.28 −13,193.28 609.44 5,486 18 8.69×10−118
Common pathway 2,407.14 −13,383.14 423.58 5,488 20 2.59×10−77
Table 6 Comparison of model
performance for the three multi-
variate models applied to lipid
phenotypes
2LL is two times the log
likelihood
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environmental backgrounds. High common environmental
correlations are estimated to explain the observed pheno-
typic correlations of BMI and triacylglycerol with all
phenotypes. Our results could indicate that cross-
phenotype correlation between BMI and other phenotypes
may lack a strong genetic background. Consequently, genes
identified as affecting BMI may not overlap with those
associated with other endophenotypes.
Assuming the existence of common genetic and envi-
ronmental factors but with different effects on the six
phenotypes, the IP model restricts and decomposes the
cross-phenotype correlation into common genetic and
environmental (including shared and unique) components
(Fig. 2). As expected, factor loading for the common
factors are mainly by the lipid phenotypes (Table 3),
meaning more shared genetic components among these
phenotypes than with the other phenotypes. In a recent
large-scale genome-wide association (GWA) analysis on
loci affecting lipid levels, many loci were associated with
multiple lipid phenotypes including total cholesterol, HDL,
LDL and triacylglycerol [11]. In contrast, the glucose
phenotype fasting glucose was largely (95%) affected by
its own phenotype-specific pathway. For BMI, the IP
accounted for more than 80% of its total variance, thus
distinguishing it from the lipid phenotypes. Of special
interest is HDL, which was affected by common factors
(59%) and independent (41%) pathways. Although the
common factor pathway explained more variance than the
phenotype-specific pathway, it is non-genetic, which suggests
that HDL may be subject to independent genetic regulation
that is different from that of the other lipid phenotypes.
The CP model further restricts the common genetic and
environmental factors in the IP model leading to the same
genetic and environmental architecture for all phenotypes
by introducing a single latent phenotype (Fig. 1). As
expected, factor loading from the latent phenotype was
mainly by the lipid phenotypes, with loading for non-lipid
phenotypes as low as 0.02 for fasting glucose and 0.03 for
BMI (Table 4). This suggests that the latent variable could
represent a common mechanism for the lipid phenotypes.
Similarly to the IP model, BMI, fasting glucose and HDL had
high factor loading on their phenotype-specific pathways.
Although meaningful outputs were obtained by all three
models, results from model comparison in Table 5 imply
that the greater the restriction in the pathway assumption,
the worse the model performance, indicating biological
heterogeneity in the development of these phenotypes. All
our models point to a clear distinction between most of the
lipid phenotypes and non-lipid phenotypes. Table 6 shows
results on performances for the full, CP and IP models,
applied only to the four lipid phenotypes with data on BMI
and fasting glucose dropped. Similarly to Table 5, perfor-
mance for the nested CP and IP models were again
compared with that of the full model. However, in contrast
to Table 5, the CP model (AIC −13,383.14) outperformed
the IP model (AIC −13,193.28), giving a clear indication of
shared genetic and environmental mechanisms among the
four lipid phenotypes (HDL, LDL, triacylglycerol and total
cholesterol), a finding consistent with conclusions from an
American study on lipid phenotypes using a pairwise
approach [1].
The existence of genetic pleiotropy in lipid phenotypes
can have an important implication for gene mapping
practice. It has already been shown that, by a joint analysis
of multiple related phenotypes, the multivariate linkage
analysis can have increased power in mapping pleiotropic
genes [12–14]. Moreover, current rapid development in
high-throughput genotyping techniques is enabling large-
scale GWA studies for the mapping of common genetic
variations with low to modest effects on possibly multiple
phenotypes including lipid phenotypes. For example, a
recent GWAS identified genetic variants that influence
obesity and osteoporosis phenotypes [15]. Based on our
results, future studies may well find that pleiotropic genes
affect lipid phenotypes in the Chinese population.
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